Ravi Nandan Singh, Ph.D.Wake Forest School of Medicine

Ravi Nandan Singh, Ph.D.

Assistant Professor,

Contact Information

Academic: 336-713-4434 | Department: 336-713-4434


Additional Languages


Education & Training

  • B.A., Harvard University, 1995
  • Ph.D., Univ of London School Of Pharmacy-United Kingdom, 2008
  • Fellowship, Cell Biology, WFU School of Medicine, 2012


  • Am Assn for Cancer Research
  • Sigma Xi - Research Society
Ravi Nandan Singh, Ph.D.

Ravi Nandan Singh, Ph.D.

Assistant Professor, Cancer Biology

Research Interests

cancer/oncogenesis, cross(mult/tnslat/inter)discip, drugs/therapeutic agents pharm, education/training (all f, t,, engineering/bioengineering, immunology/allergy/inflammatio, radiology imaging/nuclear medi

Contact Information

Academic: 336-713-4434 | Department: 336-713-4434


Recent Publications

Stuart CH, Singh R, Smith TL, D'Agostino R Jr, Caudell D, Balaji KC, Gmeiner WH. Prostate-specific membrane antigen-targeted liposomes specifically deliver the Zn(2+) chelator TPEN inducing oxidative stress in prostate cancer cells. Nanomedicine (Lond). 2016;11(10):1207-1222.

Eldridge BN, Bernish BW, Fahrenholtz CD, Singh R. Photothermal therapy of glioblastoma multiforme using multiwalled carbon nanotubes optimized for diffusion in extracellular space. ACS Biomater Sci Eng. 2016;2(6):963-976.

Swanner JL, Fahrenholtz CD, Singh RN. Systemic delivery of silver nanoparticles and targeting of the folate receptor alpha for the treatment of triple-negative breast cancer [abstract]. Mol Cancer Res. 2016;14(2 Suppl):B04.

Fahrenholtz CD, Ding S, Bernish BW, Wright M, Bierbach U, Singh RN. Self-assembling platinum-acridine loaded carbon nanotubes for triple-negative breast cancer chemotherapy [abstract]. Mol Cancer Res. 2016;14(2 Suppl):B05.

Swanner J, Mims J, Carroll DL, Akman SA, Furdui CM, Torti SV, Singh RN. Differential cytotoxic and radiosensitizing effects of silver nanoparticles on triple-negative breast cancer and non-triple-negative breast cells. Int J Nanomedicine. 2015;10():3937-3953.

Fahrenholtz CD, Hadimani M, King SB, Torti SV, Singh R. Targeting breast cancer with sugar-coated carbon nanotubes. Nanomedicine (Lond). 2015;10(16):2481-2497.

Neal RE II, Rossmeisl JH Jr, Robertson JL, Arena CB, Davis EM, Singh RN, Stallings J, Davalos RV. Improved local and systemic anti-tumor efficacy for irreversible electroporation in immunocompetent versus immunodeficient mice. PLoS One. 2013;8(5):e64559.

Singh RN, Alexander P, Burke AR, Torti FM, Torti SV. Carbon nanotubes for thermal therapy In: Cho SH, Krishnan S, eds. Cancer nanotechnology: principles and applications in radiation oncology. Boca Raton (FL): CRC Press/Taylor & Francis;2013: 205-228.

Chapman S, Dobrovolskaia M, Farahani K, Goodwin A, Joshi A, Lee H, Meade T, Pomper M, Ptak K, Rao J, Singh R, Sridhar S, Stern S, Wang A, Weaver JB, Woloschak G, Yang L. Nanoparticles for cancer imaging: the good, the bad, and the promise. Nano Today. 2013;8(5):454-460.

Singh R, Torti SV. Carbon nanotubes in hyperthermia therapy. Adv Drug Deliv Rev. 2013;65(15):2045-2060.

Burke AR, Singh RN, Carroll DL, Wood JCS, D'Agostino RB Jr, Ajayan PM, Torti FM, Torti SV. The resistance of breast cancer stem cells to conventional hyperthermia and their sensitivity to nanoparticle-mediated photothermal therapy. Biomaterials. 2012;33(10):2961-2970.

Xie B, Singh R, Torti FM, Keblinski P, Torti S. Heat localization for targeted tumor treatment with nanoscale near-infrared radiation absorbers. Phys Med Biol. 2012;57(18):5765-5775.

Burke AR, Singh RN, Carroll DL, Torti FM, Torti SV. Targeting cancer stem cells with nanoparticle-enabled therapies. J Mol Biomarkers Diagn. 2012;2012(S:8):003.

Burke AR, Singh RN, Carroll DL, Owen JD, Kock ND, D'Agostino R Jr, Torti FM, Torti SV. Determinants of the thrombogenic potential of multiwalled carbon nanotubes. Biomaterials. 2011;32(26):5970-5978.

Ding X, Singh R, Burke A, Hatcher H, Olson J, Kraft RA, Schmid M, Carroll D, Bourland JD, Akman S, Torti FM, Torti SV. Development of iron-containing multiwalled carbon nanotubes for MR-guided laser-induced thermotherapy. Nanomedicine (Lond). 2011;6(8):1341-1352.

Neal RE II, Singh R, Hatcher HC, Kock ND, Torti SV, Davalos RV. Treatment of breast cancer through the application of irreversible electroporation using a novel minimally invasive single needle electrode. Breast Cancer Res Treat. 2010;123(1):295-301.

Singh R, Kastarelos K. Designer adenoviruses for nanomedicine and nanodiagnostics. Trends Biotechnol. 2009;27(4):220-229.

Hatcher HC, Singh RN, Torti FM, Torti SV. Synthetic and natural iron chelators: therapeutic potential and clinical use. Future Med Chem. 2009;1(9):1643-1670.

Burke A, Singh R, Kraft RA, Levi-Polyachenko N, Hatcher HC, D'Agostino R Jr, Kock ND, Carroll DL, Akman S, Torti FM, Torti SV, et al. Long-term survival following a single treatment of kidney tumors with multiwalled carbon nanotubes and near-infrared radiation. Proc Natl Acad Sci U S A. 2009;106(31):12897-902.

All Publications

For a listing of recent publications, refer to PubMed, a service provided by the National Library of Medicine.

For a list of earlier publications, visit the Carpenter Library Publication Search.

Assistant Professor, Cancer Biology

Ravi Nandan Singh, Ph.D.

Ravi Nandan Singh, Ph.D.

Assistant Professor, Cancer Biology

Quick Reference

Request an Appointment
New Patients


Existing patients may contact the clinic directly.
Find a Doctor Ways to Give
USNWR 2015-2016Magnet Hospital RecognitionConsumer Choice2015 Best DoctorsJoint Commission Report

Disclaimer: The information on this website is for general informational purposes only and SHOULD NOT be relied upon as a substitute for sound professional medical advice, evaluation or care from your physician or other qualified health care provider.